多重免疫标志物轨迹整合聚类揭示严重创伤患者的不同免疫型
该研究对339例严重创伤患者ICU入住后第一周内的常见可溶性及细胞免疫标志物进行纵向聚类,再以全血免疫相关mRNA标志物进行多轨迹聚类验证。两种标志物组合均识别出两种免疫型,其中一种免疫型与医院获得性感染风险增加、死亡风险增加及住院时间延长相关,并同时表现出过度炎症和免疫抑制征象且持续存在。作者认为危重症患者的免疫系统可用两种纵向免疫型刻画,其中一种包含免疫反应持续失调和受损的患者;该方法有助于患者分层,并为以潜在免疫调节药物靶点标志物开展的进一步研究奠定基础。
要点
- 在339例严重创伤患者中,基于ICU入住首周常见可溶性及细胞免疫标志物的纵向聚类,识别出两种免疫型。
- 以全血免疫相关mRNA标志物进行多轨迹聚类,同样识别出两种免疫型。
- 其中一种免疫型与医院获得性感染风险增加、死亡风险增加及住院时间延长相关。
- 该免疫型同时表现出过度炎症和免疫抑制征象,且随时间持续存在。
- 作者认为危重症患者免疫系统可用两种纵向免疫型刻画,该方法有助于患者分层。
适用人群与场景
- 339例严重创伤患者,入住ICU后第一周内进行免疫标志物轨迹分析。
研究设计与关键结果
- 研究采用聚类方法,基于ICU入住后第一周内多种免疫标志物轨迹识别不同的患者组。
- 在339例严重创伤患者中,先对常见生物标志物(可溶性和细胞参数)进行纵向聚类,这些标志物在脓毒症免疫抑制期的变化已明确。
- 随后应用由全血免疫相关mRNA标志物组成的多轨迹聚类。
- 两组标志物均揭示两种免疫型,其中一种与较差结局相关,包括医院获得性感染风险增加、死亡风险增加和住院时间延长。
- 该免疫型表现出过度炎症和免疫抑制征象,且随时间持续存在。
证据类型、等级与局限
- 证据类型:研究论文(聚类分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,危重症患者的免疫系统可通过两种纵向免疫型进行刻画,其中一种包含免疫反应持续失调和受损的患者。
- 作者认为,该工作证实了此类方法用于患者分层的相关性,并为使用指示潜在免疫调节药物靶点的标志物开展进一步研究铺平道路。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The immune response of critically ill patients, such as those with sepsis, severe trauma, or major surgery, is heterogeneous and dynamic, but its characterization and impact on outcomes are poorly understood. Until now, the primary challenge in advancing our understanding of the disease has been to concurrently address both multiparametric and temporal aspects.
METHODS: We used a clustering method to identify distinct groups of patients, based on various immune marker trajectories during the first week after admission to ICU. In 339 severely injured patients, we initially longitudinally clustered common biomarkers (both soluble and cellular parameters), whose variations are well-established during the immunosuppressive phase of sepsis. We then applied this multi-trajectory clustering using markers composed of whole blood immune-related mRNA.
RESULTS: We found that both sets of markers revealed two immunotypes, one of which was associated with worse outcomes, such as increased risk of hospital-acquired infection and mortality, and prolonged hospital stays. This immunotype showed signs of both hyperinflammation and immunosuppression, which persisted over time.
CONCLUSION: Our study suggest that the immune system of critically ill patients can be characterized by two distinct longitudinal immunotypes, one of which included patients with a persistently dysregulated and impaired immune response. This work confirms the relevance of such methodology to stratify patients and pave the way for further studies using markers indicative of potential immunomodulatory drug targets.
参考来源
- Bodinier M, Peronnet E, Llitjos JF, et al. Integrated clustering of multiple immune marker trajectories reveals different immunotypes in severely injured patients. Crit Care. 2024. PMID: 39010113. doi:10.1186/s13054-024-04990-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。